Athenahealth, Inc.
ATHN
ATHN was delisted on the 11th of February, 2019.
212 hedge funds and large institutions have $6.13B invested in Athenahealth, Inc. in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 82 increasing their positions, 68 reducing their positions, and 42 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
21% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 68
6% more capital invested
Capital invested by funds: $5.8B → $6.13B (+$331M)
8% less funds holding
Funds holding: 231 → 212 (-19)
27% less call options, than puts
Call options by funds: $144M | Put options by funds: $197M
43% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 42
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$96.7M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$41.1M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$15.6M |
| 4 |
JP Morgan Chase
New York
|
-$10.3M |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$10.3M |
ATHN Hedge Fund Activity: Q3 2014 in Review
212 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Athenahealth, Inc. (ATHN) for Q3 2014, worth a combined $6.13B — up 5.7% from $5.8B a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of ATHN and 24 opened new positions — a net loss of 18 holders — while 68 trimmed existing stakes and 82 added.
The largest buyer was Fidelity Investments, adding an estimated $58.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $96.7M.
- 212 institutional investors held Athenahealth, Inc. (ATHN) as of Q3 2014, down from 231 in Q2 2014.
- Funds reported $6.13B of Athenahealth, Inc. stock for Q3 2014, up 5.7% quarter-over-quarter.
- 24 funds opened new Athenahealth, Inc. positions in Q3 2014 and 42 closed out, a net change of -18 holders.
- The largest Athenahealth, Inc. buyer in Q3 2014 was Fidelity Investments, an estimated $58.3M added.
- The largest Athenahealth, Inc. seller in Q3 2014 was T. Rowe Price Associates, an estimated $96.7M sold.
Based on aggregated 13F filings for Q3 2014.